Nurse Practitioner · Sioux Falls, SD
NPI
1770190993
Since 2020
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1000 E 23rd St Ste 200
Sioux Falls, SD, 57105
Phone (605) 322-3035
Groups this clinician bills Medicare through
Medicare paid, 2024
$12K
209 services
Medicare patients, 2024
105
Average age 73
Drug cost, 2024
$6.3M
1,377 prescriptions
Company payments, 2025
$37K
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jessica J Slaba was code 99214 (office e&m - established), 87 times for 45 patients. In total Jessica J Slaba billed 209 services in 7 codes, and Medicare paid $12K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-09-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 87 | 45 | $59.27 | $5,157 |
| 99213 Office E&M - Established | Facility | 55 | 40 | $36.70 | $2,019 |
| 99214 Office E&M - Established | Office | 35 | 16 | $67.10 | $2,348 |
| 99213 Office E&M - Established | Office | 18 | 16 | $46.04 | $829 |
By year: 2022 $10K for 179 services; 2023 $9,200 for 217 services; 2024 $12K for 209 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jessica J Slaba prescribed most often to Medicare patients was Acyclovir, with 161 prescriptions and refills. In total Jessica J Slaba wrote 1,377 Medicare prescriptions that cost $6.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 161 | 232 | 38 | $1,701 |
| Revlimid Lenalidomide | 148 | 148 | 26 | $2.4M |
| Hydroxyurea Generic | 105 | 174 | 22 | $1,929 |
| Dexamethasone Generic | 84 | 97 | 32 | $1,694 |
| Valacyclovir Valacyclovir Hcl | 64 | 103 | 19 | $2,583 |
| Imbruvica Ibrutinib | 47 | 47 | Under 11 | $849K |
| Calquence Acalabrutinib Maleate | 39 | 39 | Under 11 | $541K |
| Venclexta Venetoclax | 38 | 38 | Under 11 | $310K |
| Gabapentin Generic | 37 | 53 | Under 11 | $869 |
| Tramadol Hcl Generic | 29 | 29 | Under 11 | $102 |
| Brukinsa Zanubrutinib | 25 | 25 | Under 11 | $361K |
| Ondansetron Odt Ondansetron | 25 | 25 | 14 | $378 |
| Pomalyst Pomalidomide | 25 | 25 | Under 11 | $402K |
| Jakafi Ruxolitinib Phosphate | 24 | 24 | Under 11 | $282K |
| Prochlorperazine Maleate Generic | 23 | 23 | Under 11 | $275 |
Brand drugs: - claims; generic drugs: 908 claims; opioid claims: 40.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jessica J Slaba $37K ($37K in general payments such as food, travel and fees) from 10 companies. The largest payer was Geron Corporation with $31K.
| Company | Payments | Amount |
|---|---|---|
| Geron Corporation GERN | 41 | $31K |
| E.R. Squibb & Sons, L.L.C. BMY | 14 | $5,832 |
| Janssen Biotech, Inc. JNJ | 2 | $57.73 |
| Legend Biotech USA Inc. LEGN | 2 | $57.02 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $37.75 |
| Genzyme Corporation SNY | 2 | $37.72 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $27.81 |
| Adc Therapeutics America, Inc. | 1 | $15.57 |
| Teleflex LLC TFX | 1 | $14.47 |
| Janssen Scientific Affairs, LLC JNJ | 1 | $13.94 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.